# Toward a Multi-Trait Genetic Panel Targeting Training, Rehabilitation, and Chronic Disease Prevention: A Narrative Review

**Authors:** Antonio Imperatore, Cristina Mennitti, Giulia De Fonzo, Raffaele Amitrano, Alessandro Gentile, Mariella Calvanese, Fernanda Iafusco, Serena Coppola, Mattia Digno, Paola Borrelli, Barbara Lombardo, Giulia Frisso, Roberto Berni Canani, Nadia Tinto, Valeria D’Argenio, Olga Scudiero

PMC · DOI: 10.3390/genes16111309 · Genes · 2025-11-01

## TL;DR

This review explores how genetic factors influence athletic performance and health, suggesting personalized training and disease prevention based on genetic insights.

## Contribution

The paper compiles polymorphic genes linked to endurance, power, strength, injury, and chronic disease for multi-trait genetic panel development.

## Key findings

- Genes like ACE and PPARGC1A influence endurance performance through mitochondrial and oxygen regulation.
- ACTN3 and IGF1 are associated with power performance via anaerobic metabolism and muscle fiber recruitment.
- Genetic markers like FTO and PPARG are linked to chronic metabolic disease risk and can inform exercise interventions.

## Abstract

Athletic performance results from complex interactions between genetic and environmental factors. This review compiles and synthesizes available literature on polymorphic genes associated with endurance, power, and strength performance, as well as their links to injury susceptibility and chronic metabolic diseases. Endurance performance is modulated by ACE, PPARGC1A, HFE, UCP2, UCP3, CDKN1A, and PPARA, regulating mitochondrial biogenesis, oxygen utilization, and muscle fiber composition. Power performance involves ACTN3, MCT1, IGF1, AMPD1, AGT, and AGTR2, affecting anaerobic metabolism, lactate clearance, and fast-twitch fiber recruitment. Strength performance is influenced by AR, PPARG, ARK2N, MMS22L, LRPPRC, PHACTR1, and MTHFR, related to androgen signaling, muscle hypertrophy, and recovery. Injury-related genes (COL1A1, COL5A1, IL6, VEGFA, NOG) and metabolic risk genes (FTO, PPARG, ADRB3) further highlight the clinical relevance of genomics. Collectively, these insights support the application of genetic information to personalize training, enhance performance, prevent injuries, and guide exercise interventions to mitigate metabolic disease risk.

## Linked entities

- **Genes:** ACE (angiotensin I converting enzyme) [NCBI Gene 1636], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891], HFE (homeostatic iron regulator) [NCBI Gene 3077], UCP2 (uncoupling protein 2) [NCBI Gene 7351], UCP3 (uncoupling protein 3) [NCBI Gene 7352], CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026], PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465], ACTN3 (actinin alpha 3) [NCBI Gene 89], CMA1 (chymase 1) [NCBI Gene 1215], IGF1 (insulin like growth factor 1) [NCBI Gene 3479], AMPD1 (adenosine monophosphate deaminase 1) [NCBI Gene 270], AGT (angiotensinogen) [NCBI Gene 183], AGTR2 (angiotensin II receptor type 2) [NCBI Gene 186], AR (androgen receptor) [NCBI Gene 367], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], ARK2N (arkadia (RNF111) N-terminal like PKA signaling regulator 2N) [NCBI Gene 147339], MMS22L (MMS22 like, DNA repair protein) [NCBI Gene 253714], LRPPRC (leucine rich pentatricopeptide repeat containing) [NCBI Gene 10128], PHACTR1 (phosphatase and actin regulator 1) [NCBI Gene 221692], MTHFR (methylenetetrahydrofolate reductase) [NCBI Gene 4524], COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277], COL5A1 (collagen type V alpha 1 chain) [NCBI Gene 1289], IL6 (interleukin 6) [NCBI Gene 3569], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], NOG (noggin) [NCBI Gene 9241], FTO (FTO alpha-ketoglutarate dependent dioxygenase) [NCBI Gene 79068], ADRB3 (adrenoceptor beta 3) [NCBI Gene 155]

## Full-text entities

- **Genes:** PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}, ADRB3 (adrenoceptor beta 3) [NCBI Gene 155] {aka BETA3AR}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, NOG (noggin) [NCBI Gene 9241] {aka SYM1, SYNS1, SYNS1A}, ACTN3 (actinin alpha 3) [NCBI Gene 89] {aka ACTN3D}, MTHFR (methylenetetrahydrofolate reductase) [NCBI Gene 4524], AGTR2 (angiotensin II receptor type 2) [NCBI Gene 186] {aka AT2, ATGR2, MRX88}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, PHACTR1 (phosphatase and actin regulator 1) [NCBI Gene 221692] {aka DEE70, EIEE70, RPEL, RPEL1, dJ257A7.2}, AMPD1 (adenosine monophosphate deaminase 1) [NCBI Gene 270] {aka MAD, MADA, MMDD}, HFE (homeostatic iron regulator) [NCBI Gene 3077] {aka HFE1, HH, HLA-H, MVCD7, TFQTL2}, COL5A1 (collagen type V alpha 1 chain) [NCBI Gene 1289] {aka EDSC, EDSCL1, FMDMF}, UCP2 (uncoupling protein 2) [NCBI Gene 7351] {aka BMIQ4, SLC25A8, UCPH}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, FTO (FTO alpha-ketoglutarate dependent dioxygenase) [NCBI Gene 79068] {aka ALKBH9, BMIQ14, GDFD, IFEX9}, LRPPRC (leucine rich pentatricopeptide repeat containing) [NCBI Gene 10128] {aka CLONE-23970, GP130, LRP130, LSFC, MC4DN5}, UCP3 (uncoupling protein 3) [NCBI Gene 7352] {aka SLC25A9}, SLC16A1 (solute carrier family 16 member 1) [NCBI Gene 6566] {aka HHF7, MCT, MCT1, MCT1D}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026] {aka CAP20, CDKN1, CIP1, MDA-6, P21, SDI1}, MMS22L (MMS22 like, DNA repair protein) [NCBI Gene 253714] {aka C6orf167, dJ39B17.2}
- **Diseases:** Chronic Disease (MESH:D002908), metabolic disease (MESH:D008659), muscle hypertrophy (MESH:C536106)
- **Chemicals:** lactate (MESH:D019344), oxygen (MESH:D010100)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12652476/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12652476/full.md

## References

434 references — full list in the complete paper: https://tomesphere.com/paper/PMC12652476/full.md

---
Source: https://tomesphere.com/paper/PMC12652476